Literature DB >> 17381681

Direct measurements of nitric oxide release in relation to expression of endothelial nitric oxide synthase in isolated porcine mitral valves.

S G Moesgaard1, L H Olsen, B Aasted, B M Viuff, L G Pedersen, H D Pedersen, A P Harrison.   

Abstract

The aim of this study was to measure the direct release of nitric oxide (NO) from the porcine mitral valve using a NO microelectrode. Furthermore, the expression and localization of endothelial nitric oxide synthase (eNOS) in the mitral valve was studied using immunohistochemistry, Western blotting and RT-PCR. Results show that bradykinin increases NO release from mitral valves (DeltaBradykinin: 33.71 +/- 10.41 nm NO, P < 0.001, n = 10), whereas N-nitro-l-arginine methyl esther (l-NAME) decreases NO release when compared with basal level (Deltal-NAME: 82.69 +/- 15.66 nm NO, P < 0.005, n = 4). Both protein and mRNA expression of eNOS in mitral valves and in isolated valvular endothelial cells suggest that the NO release is mainly associated with the mitral valve endothelium. It is concluded that direct NO release from porcine mitral valves coincides with eNOS expression. This study documents useful techniques for investigations into the role of local NO release in mitral valve diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17381681     DOI: 10.1111/j.1439-0442.2007.00915.x

Source DB:  PubMed          Journal:  J Vet Med A Physiol Pathol Clin Med        ISSN: 0931-184X


  2 in total

1.  Nitric oxide formation by lymphatic bulb and valves is a major regulatory component of lymphatic pumping.

Authors:  H Glenn Bohlen; Olga Yu Gasheva; David C Zawieja
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-02       Impact factor: 4.733

2.  Plasma proANP and SDMA and microRNAs are associated with chronic mitral regurgitation in a pig model.

Authors:  Susanna Cirera; Sophia G Moesgaard; Nora E Zois; Nathja Ravn; Jens P Goetze; Signe E Cremer; Tom Teerlink; Páll S Leifsson; Jesper L Honge; J Michael Hasenkam; Lisbeth H Olsen
Journal:  Endocr Connect       Date:  2013-09-24       Impact factor: 3.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.